Life sciences · Observational Study
ClinicalTrials.gov · October 29, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Observational Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07905638). This is a study registration, not published results. Lead sponsor: Centre Hospitalier Universitaire de la Guadeloupe. Recruitment status: NOT_YET_RECRUITING. Study type: OBSERVATIONAL. Enrollment: 210 participants (ESTIMATED). Conditions: Urinary Tract Infections. Interventions: GENETIC: Whole-genome sequencing (WGS) of E. coli isolates (applies to all 3 groups). Primary outcome measures: Differential frequency of virulence genes or gene clusters in E. coli isolates, compared according to the severity level of community-acquired urinary tract infection , At the end of the 12-month inclusion period. Brief summary: The aim is to identify genomic determinants (genes or gene clusters) associated with the severity of community-acquired E. coli urinary tract infections in Guadeloupe through a comparative approach integrating clinical, microbiological, and genomic data (GWAS approach).